Abstract

The hemodynamic effects of an oral angiotensin-converting enzyme inhibitor, captopril, were evaluated in 10 symptomatic patients with chronic congestive heart failure. In all patients there was a significant increase in cardiac output (average 28%), stroke volume (49%), and stroke work index (26%), along with a decrease in pulmonary capillary wedge pressure (48%), indicating improved left ventricular function. Modest decreases in heart rate and arterial pressure were also observed. In seven patients maintained on captopril therapy, repeat hemodynamic studies at 2 months revealed sustained effects. These beneficial hemodynamic effects were accompanied by clinical improvement and improved exercise tolerance during maintenance therapy. These findings suggest that captopril may be a useful therapeutic adjunct for the long-term management of patients with chronic congestive heart failure.

Keywords

MedicineCaptoprilPulmonary wedge pressureHeart failureHemodynamicsCardiologyInternal medicineStroke volumeCardiac indexCardiac outputAngiotensin-converting enzymeBlood pressureACE inhibitorHeart rateEjection fraction

MeSH Terms

AdministrationOralAdultAgedAngiotensin-Converting Enzyme InhibitorsBlood PressureCaptoprilCardiac OutputChronic DiseaseFemaleFollow-Up StudiesHeart FailureHeart RateHemodynamicsHumansMaleMiddle AgedProlineVascular Resistance

Related Publications

Publication Info

Year
1980
Type
article
Volume
61
Issue
5
Pages
931-937
Citations
292
Access
Closed

Citation Metrics

292
OpenAlex
0
Influential

Cite This

Robert Ader, Kanu Chatterjee, Thomas A. Ports et al. (1980). Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.. Circulation , 61 (5) , 931-937. https://doi.org/10.1161/01.cir.61.5.931

Identifiers

DOI
10.1161/01.cir.61.5.931
PMID
6244906

Data Quality

Data completeness: 86%